최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biomolecules, v.10 no.1, 2020년, pp.57 -
Lee, Sullim (Department of Life Science, College of Bio-Nano Technology, Gachon University, Seongnam 13120, Korea) , Jegal, Hyun (sullimlee@gachon.ac.kr) , Bong, Sim-Kyu (Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Korea) , Yoon, Kyeong-No (wprkfgus3@gmail.com (H.J.)) , Park, No-June (115044@kist.re.kr (S.-K.B.)) , Shin, Myoung-Sook (kyeongnoyoon@naver.com (K.-N.Y.)) , Yang, Min Hye (parknojune@kist.re.kr (N.-J.P.)) , Kim, Yong Kee (Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451, Korea) , Kim, Su-Nam (wprkfgus3@gmail.com (H.J.))
To investigate the potential effects of acorn shells on atopic dermatitis (AD), we utilized oxazolone (OX)- or 2,4-dinitrochlorobenzene (DNCB)-induced AD-like lesion mouse models. Our research demonstrates that Acorn shell extract (ASE) improved the progression of AD-like lesions, including swelling...
1. Hanifin J.M. Tofte S.J. Update on therapy of atopic dermatitis J. Allergy Clin. Immunol. 1999 104 S123 S125 10.1016/S0091-6749(99)70054-0 10482863
2. Theoharides T.C. Alysandratos K.-D. Angelidou A. Delivanis D.-A. Sismanopoulos N. Zhang B. Asadi S. Vasiadi M. Weng Z. Miniati A. Mast cells and inflammation Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2012 1822 21 33 10.1016/j.bbadis.2010.12.014 21185371
3. De Benedetto A. Agnihothri R. McGirt L.Y. Bankova L.G. Beck L.A. Atopic dermatitis: A disease caused by innate immune defects? J. Investig. Dermatol. 2009 129 14 30 10.1038/jid.2008.259 19078985
4. Tokura Y. Atopic dermatitis: Common extrinsic and enigmatic intrinsic types Immunology of the Skin Springer Tokyo, Japan 2016 339 358
5. Darlenski R. Kazandjieva J. Hristakieva E. Ruhr J.W. Atopic dermatitis as a systemic disease Clin. Dermatol. 2014 32 409 413 10.1016/j.clindermatol.2013.11.007 24767188
6. Poulsen L.K. Hummelshoj L. Triggers of IgE class switching and allergy development Ann. Med. 2007 39 440 456 10.1080/07853890701449354 17852040
7. Poulsen L. Bindslev-Jensen C. Diamant M. Hansen M. Jepsen K. Reimert C. Bendtzen K. Biomolecular regulation of the IgE immune response III. Cytokine profiles in atopic dermatitis, inhalant allergy and non-allergic donors Cytokine 1996 8 651 657 10.1006/cyto.1996.0087 8894441
8. Martins J.C. Martins C. Aoki V. Gois A.F. Ishii H.A. da Silva E.M. Topical tacrolimus for atopic dermatitis Cochrane Database Syst. Rev. 2015 7 CD009864 10.1002/14651858.CD009864.pub2
9. Huang X. Xu B. Efficacy and safety of tacrolimus versus pimecrolimus for the treatment of atopic dermatitis in children: A network meta-analysis Dermatology 2015 231 41 49 10.1159/000381948 26043855
10. Hengge U.R. Ruzicka T. Schwartz R.A. Cork M.J. Adverse effects of topical glucocorticosteroids J. Am. Acad. Dermatol. 2006 54 1 15 10.1016/j.jaad.2005.01.010 16384751
11. Charman C. Morris A. Williams H. Topical corticosteroid phobia in patients with atopic eczema Br. J. Dermatol. 2000 142 931 936 10.1046/j.1365-2133.2000.03473.x 10809850
12. Nghiem P. Pearson G. Langley R.G. Tacrolimus and pimecrolimus: From clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis J. Am. Acad. Dermatol. 2002 46 228 241 10.1067/mjd.2002.120942 11807435
13. Hanifin J.M. Cooper K.D. Ho V.C. Kang S. Krafchik B.R. Margolis D.J. Schachner L.A. Sidbury R. Whitmore S.E. Sieck C.K. Guidelines of care for atopic dermatitis J. Am. Acad. Dermatol. 2004 50 391 404 10.1016/j.jaad.2003.08.003 14988682
14. Bainbridge D.A. Use of Acorns for Food in California: Past, Present, Future Proceedings of the Symposium on Multiple-use Management of California’s Hardwoods San Luis Obispo, CA, USA 12?14 November 1986 453 458
15. Custodio L. Patarra J. Albericio F. Neng N.R. Nogueira J.M.F. Romano A. Extracts from Quercus sp. acorns exhibit in vitro neuroprotective features through inhibition of cholinesterase and protection of the human dopaminergic cell line SH-SY5Y from hydrogen peroxide-induced cytotoxicity Ind. Crop. Prod. 2013 45 114 120 10.1016/j.indcrop.2012.12.011
16. Huang J. Wang Y. Li C. Wang X. He X. Triterpenes isolated from acorns of Quercus serrata var. brevipetiolata exert anti-inflammatory activity Ind. Crop. Prod. 2016 91 302 309 10.1016/j.indcrop.2016.07.033
17. Huang J. Wang Y. Li C. Wang X. He X. Anti-inflammatory oleanolic triterpenes from Chinese Acorns Molecules 2016 21 669 10.3390/molecules21050669
18. Sheu S.-Y. Tsuang Y.-H. Hsu F.-L. Lu F.-J. Chiang H.-C. Superoxide Anion Scavenge Effect of Quercs glauca Thunb. in Whole Blood of Patients with Ankylosing Spondylitis Am. J. Chin. Med. 1997 25 307 315 10.1142/S0192415X97000342 9358904
19. Yarani R. Mansouri K. Mohammadi-Motlagh H.R. Mahnam A. Emami Aleagha M.S. In Vitro inhibition of angiogenesis by hydroalcoholic extract of oak ( Quercus infectoria ) acorn shell via suppressing VEGF, MMP-2, and MMP-9 secretion Pharm. Biol. 2013 51 361 368 10.3109/13880209.2012.729147 23137183
20. Almeida I.F. Fernandes E. Lima J.L. Costa P. Bahia M. Protective effect of Castanea sativa and Quercus robur leaf extracts against oxygen and nitrogen reactive species J. Photochem. Photobiol. B Biol. 2008 91 87 95 10.1016/j.jphotobiol.2008.02.001
21. Basri D.F. Fan S. The potential of aqueous and acetone extracts of galls of Quercus infectoria as antibacterial agents Indian J. Pharmacol. 2005 37 26 10.4103/0253-7613.13851
22. Gulluce M. Adıguzel A. Outcu H. engul M. Karaman I. ahin F. Antimicrobial effects of Quercus ilex L. extract Phytother. Res. Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2004 18 208 211
23. Vinha A.F. Barreira J.C. Costa A.S. Oliveira M.B.P. A new age for Quercus spp. fruits: Review on nutritional and phytochemical composition and related biological activities of acorns Compr. Rev. Food Sci. Food Saf. 2016 15 947 981 10.1111/1541-4337.12220
24. Kay A.B. Calcitonin gene-related peptide?and vascular endothelial growth factor?positive inflammatory cells in late-phase allergic skin reactions in atopic subjects J. Allergy Clin. Immunol. 2011 127 232 237 10.1016/j.jaci.2010.10.028 21211657
25. Lee S. Park N.-J. Bong S.-K. Jegal J. Park S.-A. Kim S.-N. Yang M.H. Ameliorative effects of Juniperus rigida fruit on oxazolone-and 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice J. Ethnopharmacol. 2018 214 160 167 10.1016/j.jep.2017.12.022 29258854
26. Schmittgen T.D. Livak K.J. Analyzing real-time PCR data by the comparative C T method Nat. Protoc. 2008 3 1101 10.1038/nprot.2008.73 18546601
27. Jung Y. Kim J.-C. Park N.-J. Bong S.-K. Lee S. Jegal H. Jin L.T. Kim S.M. Kim Y.K. Kim S.-N. Eupatilin, an activator of PPARα, inhibits the development of oxazolone-induced atopic dermatitis symptoms in Balb/c mice Biochem. Biophys. Res. Commun. 2018 496 508 514 10.1016/j.bbrc.2018.01.098 29353040
28. Huang F. Yamaki K. Tong X. Fu L. Zhang R. Cai Y. Yanagisawa R. Inoue K.-I. Takano H. Yoshino S. Inhibition of the antigen-induced activation of RBL-2H3 cells by sinomenine Int. Immunopharmacol. 2008 8 502 507 10.1016/j.intimp.2007.12.009 18279805
29. Novak N. Bieber T. Leung D.Y. Immune mechanisms leading to atopic dermatitis J. Allergy Clin. Immunol. 2003 112 S128 S139 10.1016/j.jaci.2003.09.032 14657843
30. Shirakawa T. Deichmann K.A. Izuhara K. Mao X.-Q. Adra C.N. Hopkin J.M. Atopy and asthma: Genetic variants of IL-4 and IL-13 signalling Immunol. Today 2000 21 60 64 10.1016/S0167-5699(99)01492-9 10652462
31. Zhu Z. Zheng T. Homer R.J. Kim Y.-K. Chen N.Y. Cohn L. Hamid Q. Elias J.A. Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation Science 2004 304 1678 1682 10.1126/science.1095336 15192232
32. Leung D.Y. Boguniewicz M. Howell M.D. Nomura I. Hamid Q.A. New insights into atopic dermatitis J. Clin. Investig. 2004 113 651 657 10.1172/JCI21060 14991059
33. Maggi E. Del Prete G. Tiri A. Macchia D. Parronchi P. Ricci M. Romagnani S. T cell clones providing helper function for IgE synthesis release soluble factor (s) that induce IgE production in human B cells: Possible role for interleukin 4 (IL-4) Clin. Exp. Immunol. 1988 73 57 2971487
34. Del Prete G. Maggi E. Parronchi P. Chretien I. Tiri A. Macchia D. Ricci M. Banchereau J. De Vries J. Romagnani S. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants J. Immunol. 1988 140 4193 4198 2967330
35. Man M.-Q. Hatano Y. Lee S.H. Man M. Chang S. Feingold K.R. Leung D.Y. Holleran W. Uchida Y. Elias P.M. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: Structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges J. Investig. Dermatol. 2008 128 79 86 10.1038/sj.jid.5701011 17671515
36. Peiser M. Tralau T. Heidler J. Api A. Arts J. Basketter D. English J. Diepgen T. Fuhlbrigge R. Gaspari A. Allergic contact dermatitis: Epidemiology, molecular mechanisms, in vitro methods and regulatory aspects Cell. Mol. Life Sci. 2012 69 763 781 10.1007/s00018-011-0846-8 21997384
37. Kim D. Kobayashi T. Nagao K. Research Techniques Made Simple: Mouse Models of Atopic Dermatitis J. Investig. Dermatol. 2019 139 984.e1 990.e1 10.1016/j.jid.2019.02.014 31010529
38. Nakajima S. Nomura T. Common J. Kabashima K. Insights into atopic dermatitis gained from genetically defined mouse models J. Allergy Clin. Immunol. 2019 143 13 25 10.1016/j.jaci.2018.11.014 30612664
39. Jin H. He R. Oyoshi M. Geha R.S. Animal models of atopic dermatitis J. Investig. Dermatol. 2009 129 31 40 10.1038/jid.2008.106 19078986
40. Brandt E.B. Sivaprasad U. Th2 cytokines and atopic dermatitis J. Clin. Cell. Immunol. 2011 2 110 10.4172/2155-9899.1000110 21994899
41. Fujii Y. Takeuchi H. Sakuma S. Sengoku T. Takakura S. Characterization of a 2,4-dinitrochlorobenzene-induced chronic dermatitis model in rats Ski. Pharmacol. Physiol. 2009 22 240 247 10.1159/000235551
42. Iikura M. Yamaguchi M. Hirai K. Miyamasu M. Yamada H. Nakajima T. Fujisawa T. Ra C. Morita Y. Yamamoto K. Regulation of surface FcεRI expression on human eosinophils by IL-4 and IgE Int. Arch. Allergy Immunol. 2001 124 470 477 10.1159/000053782 11340330
43. Park S. Lee J.B. Kang S. Topical application of Chrysanthemum indicum L. Attenuates the development of atopic dermatitis-like skin lesions by suppressing serum IgE levels, IFN-γ, and IL-4 in Nc/Nga mice Evid.-Based Complement. Altern. Med. 2012 2012 821967 10.1155/2012/821967 22454686
44. Marsella R. Olivry T. Carlotti D.N. International Task Force on Canine Atopic Dermatitis Current evidence of skin barrier dysfunction in human and canine atopic dermatitis Vet. Dermatol. 2011 22 239 248 10.1111/j.1365-3164.2011.00967.x 21414049
45. Addor F.A. Takaoka R. Rivitti E.A. Aoki V. Atopic dermatitis: Correlation between non-damaged skin barrier function and disease activity Int. J. Dermatol. 2012 51 672 676 10.1111/j.1365-4632.2011.05176.x 22607284
46. Liu F.-T. Goodarzi H. Chen H.-Y. IgE, mast cells, and eosinophils in atopic dermatitis Clin. Rev. Allergy Immunol. 2011 41 298 310 10.1007/s12016-011-8252-4 21249468
47. Homey B. Steinhoff M. Ruzicka T. Leung D.Y. Cytokines and chemokines orchestrate atopic skin inflammation J. Allergy Clin. Immunol. 2006 118 178 189 10.1016/j.jaci.2006.03.047 16815153
48. Jensen J.-M. Pfeiffer S. Witt M. Brautigam M. Neumann C. Weichenthal M. Schwarz T. Folster-Holst R. Proksch E. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis J. Allergy Clin. Immunol. 2009 124 R19 R28 10.1016/j.jaci.2009.07.015 19720208
49. Mastuda H. Morikawa T. Ueda K. Managi H. Yoshikawa M. Structural requirements of flavonoids for inhibition of antigen-induced degranulation, TNF-α and IL-4 production from RBL-2H3 cells Bioorgan. Med. Chem. 2002 10 3123 3128 10.1016/S0968-0896(02)00227-4
50. Jegal J. Park N.-J. Jo B.-G. Bong S.-K. Jegal H. Yang M. Kim S.-N. Anti-Atopic Properties of Gracillin Isolated from Dioscorea quinqueloba on 2,4-Dinitrochlorobenzene-Induced Skin Lesions in Mice Nutrients 2018 10 1205 10.3390/nu10091205
51. Jo B.-G. Park N.-J. Jegal J. Choi S. Lee S.W. Yi L.W. Kim S.-N. Yang M.H. Stellera chamaejasme and its main compound luteolin 7-o-glucoside alleviates skin lesions in oxazolone-and 2,4-dinitrochlorobenzene-stimulated murine models of atopic dermatitis Planta Med. 2019 85 583 590 10.1055/a-0746-8698 30273950
52. Kim S.-H. Jun C.-D. Suk K. Choi B.-J. Lim H. Park S. Lee S.H. Shin H.-Y. Kim D.-K. Shin T.-Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells Toxicol. Sci. 2005 91 123 131 10.1093/toxsci/kfj063 16322071
53. Kroes B.V. Van den Berg A. Van Ufford H.Q. Van Dijk H. Labadie R. Anti-inflammatory activity of gallic acid Planta Med. 1992 58 499 504 10.1055/s-2006-961535 1336604
54. Choi Y.H. Yan G.H. Ellagic Acid attenuates immunoglobulin E-mediated allergic response in mast cells Biol. Pharm. Bull. 2009 32 1118 1121 10.1248/bpb.32.1118 19483327
55. Rogerio A.P. Fontanari C. Borducchi E. Keller A.C. Russo M. Soares E.G. Albuquerque D.A. Faccioli L.H. Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma Eur. J. Pharmacol. 2008 580 262 270 10.1016/j.ejphar.2007.10.034 18021768
※ AI-Helper는 부적절한 답변을 할 수 있습니다.